Intestinal innate immunity Nutritional, Metabolic, Endocrine Nutritional supplementation
Conditions
Interventions
Randomised, placebo-controlled trial of solid tablet formulation of 15 micronutrients, administered daily, with cross-over after two years.
The anticipated end date of this trial has been shortened t
Sponsors
London School of Hygiene and Tropical Medicine (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All adults (over 18 years of age, either sex) resident within a defined geographical area of Misisi compound, Lusaka, Zambia, have been invited to participate.
Exclusion criteria
Exclusion criteria: Does not meet inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Frequency of diarrhoeal disease 2. CD4 count in human immunodeficiency virus (HIV) seropositive participants 3. Expression of antimicrobial peptides in small intestinal tissue and secretions 4. Change in micronutrient status | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcome measures | — |
Countries
Zambia
Outcome results
None listed